2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
- PMID: 37622663
- DOI: 10.1093/eurheartj/ehad192
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Erratum in
-
Correction to: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC).Eur Heart J. 2023 Dec 21;44(48):5060. doi: 10.1093/eurheartj/ehad774. Eur Heart J. 2023. PMID: 37989571 No abstract available.
-
Correction to: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC).Eur Heart J. 2024 Feb 16;45(7):518. doi: 10.1093/eurheartj/ehad857. Eur Heart J. 2024. PMID: 38247449 No abstract available.
Keywords: Aortic and peripheral arterial diseases; Arrhythmias; Atrial fibrillation; Cardiovascular disease; Cardiovascular risk assessment; Chronic kidney disease; Coronary artery disease; Diabetes mellitus; Guidelines; Heart failure; Patient-centred care; Pharmacological treatment; Prevention; Risk factors.
Similar articles
-
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548. Diab Vasc Dis Res. 2014. PMID: 24800783 No abstract available.
-
[Recommendations for cardiovascular rehabilitation in diabetes mellitus].Monaldi Arch Chest Dis. 2003 Dec;60(4):263-82. Monaldi Arch Chest Dis. 2003. PMID: 15061601 Italian.
-
[Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023].Herz. 2024 Feb;49(1):15-18. doi: 10.1007/s00059-023-05218-x. Epub 2023 Oct 25. Herz. 2024. PMID: 37878038 Review. German.
-
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.Eur Heart J. 2024 Apr 14;45(15):1298-1300. doi: 10.1093/eurheartj/ehad881. Eur Heart J. 2024. PMID: 38195096 No abstract available.
-
Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management.J Transl Med. 2017 May 25;15(1):114. doi: 10.1186/s12967-017-1211-y. J Transl Med. 2017. PMID: 28545542 Free PMC article. Review.
Cited by
-
Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition).J Transl Int Med. 2024 Oct 1;12(4):325-343. doi: 10.2478/jtim-2024-0014. eCollection 2024 Sep. J Transl Int Med. 2024. PMID: 39360162 Free PMC article.
-
Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy.Front Endocrinol (Lausanne). 2024 Jul 30;15:1451100. doi: 10.3389/fendo.2024.1451100. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39140033 Free PMC article. Review.
-
Heart Failure With Preserved Ejection Fraction and Frailty: From Young to Superaged Coexisting HFpEF and Frailty.Int J Heart Fail. 2024 Jun 21;6(3):93-106. doi: 10.36628/ijhf.2023.0064. eCollection 2024 Jul. Int J Heart Fail. 2024. PMID: 39081641 Free PMC article. Review.
-
Western diets and chronic diseases.Nat Med. 2024 Aug;30(8):2133-2147. doi: 10.1038/s41591-024-03165-6. Epub 2024 Jul 31. Nat Med. 2024. PMID: 39085420 Review.
-
A Novel 5-Chloro-N-Phenyl-1 H-Indole-2-carboxamide Derivative as a Glycogen Phosphorylase Inhibitor: Evaluating the Long-Term Drug Effects on Muscle Function for the First Time.Molecules. 2024 Sep 19;29(18):4448. doi: 10.3390/molecules29184448. Molecules. 2024. PMID: 39339443 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical